NEI/FDA CDER Glaucoma Clinical Drug Trial Design and Endpoints Symposium

News Brief
03/13/08

Natcher Auditorium
National Institutes of Health
Bethesda, Maryland
March 13-14, 2008

The National Eye Institute (NEI) and the Food and Drug Administration (FDA) are sponsoring a symposium to consider new disease-relevant outcome measures appropriate for evaluating glaucoma therapies.

For additional information and to register for the symposium, please visit the Association for Research
in Vision and Ophthalmology (ARVO) website at http://www.arvo.org/endpoints.